Data / Form D filings / VACCINOGEN INC
VACCINOGEN INC: Form D filings
VACCINOGEN INC, a biotechnology company in Baltimore, MD, filed 12 Form D notices with the SEC between 2010 and 2015. The latest, on November 9, 2015, reports $600,000 sold of a $3 million offering to 4 investors.
Find out what VACCINOGEN INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 949 FELL STREET, Baltimore, MD, 21231
- Phone
- (410) 387-4000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Maryland
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1453001
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2015 | New notice | $3,000,000 | $600,000 | $2,400,000 | 4 | Oct 27, 2015 | sec.gov |
| Aug 24, 2015 | Amendment | Indefinite | $0 | Indefinite | 7 | Apr 1, 2015 | sec.gov |
| Aug 20, 2015 | New notice | Indefinite | $0 | Indefinite | 7 | Yet to occur | sec.gov |
| Aug 20, 2015 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | sec.gov |
| Jan 24, 2014 | Amendment | $13,038,003 | $6,642,878 | $6,395,125 | 68 | Oct 23, 2012 | sec.gov |
| Mar 22, 2013 | New notice | $11,000,000 | $2,061,565 | $8,938,435 | 22 | Oct 23, 2012 | sec.gov |
| Sep 4, 2012 | New notice | Indefinite | $0 | Indefinite | 1 | Jul 18, 2012 | sec.gov |
| Jun 3, 2011 | Amendment | $35,000,000 | $7,600,000 | $27,400,000 | 25 | Feb 5, 2010 | sec.gov |
| Oct 14, 2010 | New notice | Indefinite | $0 | Indefinite | 1 | Sep 4, 2010 | sec.gov |
| Jul 2, 2010 | New notice | Indefinite | $0 | Indefinite | 1 | Jun 24, 2010 | sec.gov |
| Mar 11, 2010 | New notice | $35,000,000 | $2,750,000 | $32,250,000 | 4 | Feb 5, 2010 | sec.gov |
| Feb 19, 2010 | Amendment | $4,008,472 | $4,008,472 | $0 | 66 | Dec 3, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael G. Hagerman | Director | |
| Hakan G. Edstrom | Director | |
| Anders G. Halldin | Director | |
| Michael G. Hanna, Jr. | Director | |
| Andrew L. Tussing | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- BlueHealer Inc. $1 · Nov 4, 2026
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
- Gliknik Inc $15 million · Sep 17, 2026
- Georgiamune, Inc. $92.7 million · Aug 17, 2026
Every Form D from the week of Nov 9, 2015 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what VACCINOGEN INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.